Ingenza announces move to purpose-built facilities to expand fermentation and research capacity

Ingenza – a world-leading contract research, development, and manufacturing organization (CRDMO) and technology accelerator – is delighted to announce its plans to relocate to the Moubray Building at Edinburgh Technopole, part of Pioneer Group. Following a detailed strategic review, the company has embarked on the creation of a multi-million-pound facility to help drive its ambitious growth plans. The purpose-built premises will more than double Ingenza’s current footprint to approximately 25,000 square feet, expanding its fermentation and research facilities.

Ingenza announces move to purpose-built facilities to expand fermentation and research capacity

Image Credit: Ingenza

Jaymin Amin, Chief Business Officer of Ingenza, explained: “The expansion is a landmark investment for Ingenza, enabling us to increase our fermentation scale to 100L, as well as expanding our research and development labs to support larger programs. Our inGenius platform technology is redefining drug substance development and sustainable biotech manufacturing, and this exciting move will provide an independent, world-class facility to better serve customers worldwide, accelerating our business growth.”

We are delighted that Ingenza will be located with us at Edinburgh Technopole. As a UK and world leader in industrial biotechnology, Ingenza is a very welcome addition to Pioneer’s ecosystem. Importantly, the business is remaining in the Midlothian Science Zone, while expanding its lab and office operations and creating 50 new highly skilled jobs. Ingenza’s growth is hugely positive for our local life sciences cluster, being an exemplar of the Pioneer model of local economic development, partnership and impact that will accelerate scientific discovery.

John Mackenzie, Director (Scotland) at Pioneer

Ingenza anticipates moving into the new facility in Q2 of 2025.

Source:

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Ingenza Ltd. (2024, October 07). Ingenza announces move to purpose-built facilities to expand fermentation and research capacity. News-Medical. Retrieved on October 07, 2024 from https://www.news-medical.net/news/20241007/Ingenza-announces-move-to-purpose-built-facilities-to-expand-fermentation-and-research-capacity.aspx.

  • MLA

    Ingenza Ltd. "Ingenza announces move to purpose-built facilities to expand fermentation and research capacity". News-Medical. 07 October 2024. <https://www.news-medical.net/news/20241007/Ingenza-announces-move-to-purpose-built-facilities-to-expand-fermentation-and-research-capacity.aspx>.

  • Chicago

    Ingenza Ltd. "Ingenza announces move to purpose-built facilities to expand fermentation and research capacity". News-Medical. https://www.news-medical.net/news/20241007/Ingenza-announces-move-to-purpose-built-facilities-to-expand-fermentation-and-research-capacity.aspx. (accessed October 07, 2024).

  • Harvard

    Ingenza Ltd. 2024. Ingenza announces move to purpose-built facilities to expand fermentation and research capacity. News-Medical, viewed 07 October 2024, https://www.news-medical.net/news/20241007/Ingenza-announces-move-to-purpose-built-facilities-to-expand-fermentation-and-research-capacity.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Ingenza announces partnership with Cellugy to investigate the potential of biofabricated cellulose